Undernutrition is a prevalent condition in pediatric malignancy patients leading to unfavorable outcomes. The aim of this retrospective study was to determine the nutritional status and rate of undernutrition in 174 Hungarian pediatric patients with malignancies and the impact on 5-year survival based on anthropometric measurements. At the time of diagnosis, 5.0%, 4.6%, and 4.0% of patients were undernourished as determined by body weight (BW), weight-for-height (WFH), and body mass index (BMI) Z-score, respectively. The rate of undernutrition was 30.5% using ideal body weight percent (IBW%). Undernutrition at the time of diagnosis worsened the five-year overall survival only in solid tumor patients as defined by BMI Z-score and IBW%. Furthermore, 26.5% of patients became undernourished based on IBW% during the treatment period. Deterioration of nutritional status during treatment unfavorably influenced overall survival in both hematological and solid tumor subsets. Abnormal BW, WFH, and BMI Z-score were associated with poor prognosis in the hematologic group. The mortality risk was higher among hematologic patients with weight loss exceeding 20%. In conclusion, IBW% seems to be the most sensitive parameter to estimate undernutrition. Furthermore, BMI Z-score in both groups and severe weight loss in the hematological group may influence clinical outcome and play a role in prognosis assessment.
Malnutrition and inflammatory bowel disease (IBD) are interrelated conditions. Our aim was to assess the prevalence of malnutrition, to compare anthropometric parameters in the evaluation of nutritional status in pediatric IBD, and to investigate the association between anthropometric parameters and disease activity indices (AI). Pediatric patients with newly diagnosed IBD recorded between 2010 and 2016 in the Hungarian Pediatric IBD Registry were included in this cross-sectional study. Body weight, body mass index (BMI), weight-for-height, and ideal body weight percent (IBW%) were analyzed. Pearson linear and non-linear correlations and polynomial regression analyses were performed to assess correlation between nutritional status and AI. p-values < 0.05 were considered significant. Anthropometric data of 1027 children with IBD (Crohn’s disease (CD): 699; ulcerative colitis (UC): 328; mean age 13.7 years) were analyzed. IBW% identified more obese patients than BMI both in CD (7.02% vs. 2.28%) and UC (12.17% vs. 5.48%). Significant negative correlation was found among anthropometric parameters and AI in CD. In contrast, polynomial regression analysis revealed a U-shaped correlation curve between IBW% and AI in UC. Our findings show that obesity has a bimodal association with disease activity in pediatric UC. Furthermore, IBW% was more useful to identify obese pediatric patients with IBD.
Background/Objectives: Nutritional therapy in pediatric Crohn’s disease has evolved during the last decade. Exclusive enteral nutrition (EEN) has been proven to improve nutritional status and serves as an effective induction treatment. However, its long-term benefits compared to corticosteroids (CS) remain uncertain. We aimed to assess long-term disease outcomes by induction therapy and the impact of early treatment response. Methods: This is a post hoc analysis using data from the prospective, nationwide Hungarian Pediatric IBD Registry (HUPIR). Children diagnosed with Crohn’s disease between 2011 and 2016 who initiated EEN or CS at diagnosis were included. We analyzed main outcomes such as clinical relapse, initiation of biologic therapy, and intestinal resection using interval-censored survival analysis and multivariable Cox regression models. We assessed treatment response at 3 months after diagnosis. Results: A total of 331 children (male: 193 (58%); mean (SD) age: 14.4+/−3.2 yrs) met the inclusion criteria and received either EEN (n = 115) or CS (n = 216). Biologic therapy-free survival was higher in the EEN group compared with the CS group (p = 0.025). In contrast, relapse-free and surgical-free survival did not differ between groups (p = 0.081 and p = 0.640, respectively). Non-response at 3 months to induction therapy showed lower relapse-free and biologic therapy-free survival (p = 0.005 and p < 0.001, respectively). Among responders, outcomes were comparable between EEN and CS. Conclusions: Early treatment response, rather than induction strategy, is strongly associated with long-term outcomes in pediatric Crohn’s disease, underscoring the importance of close monitoring and timely therapeutic adjustment.